Back to the future: host-targeted chemotherapeutics for drug-resistant TB

被引:0
作者
Napier, Ruth J.
Shinnick, Thomas M.
Kalman, Daniel [1 ]
机构
[1] Emory Univ, Dept Pathol & Lab Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA
关键词
Abl tyrosine kinase; antibiotic resistance; drug resistance; Gleevec; imatinib; MDR-TB; tuberculosis; XDR-TB; SARCOMA-VIRUS; TYROSINE KINASES; PHILADELPHIA-CHROMOSOME; ABL; IMATINIB; TUBERCULOSIS; GENE; PATHOGENESIS; STREPTOMYCIN; INHIBITION;
D O I
10.2217/FMB.12.19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:431 / 435
页数:5
相关论文
共 56 条
[1]  
American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1
[2]   Cancer genetics: from Boveri and Mendel to microarrays [J].
Balmain, A .
NATURE REVIEWS CANCER, 2001, 1 (01) :77-82
[3]   Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects [J].
Bolton, AE ;
Peng, B ;
Hubert, M ;
Krebs-Brown, A ;
Capdeville, R ;
Keller, U ;
Seiberling, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (02) :102-106
[4]   Abl tyrosine kinases are required for infection by Shigella flexneri [J].
Burton, EA ;
Plattner, R ;
Pendergast, AM .
EMBO JOURNAL, 2003, 22 (20) :5471-5479
[5]  
Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P301
[6]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[7]   PROTEIN-KINASE ACTIVITY ASSOCIATED WITH AVIAN-SARCOMA VIRUS SRC GENE PRODUCT [J].
COLLETT, MS ;
ERIKSON, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :2021-2024
[8]   Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions [J].
Coyne, CB ;
Bergelson, JM .
CELL, 2006, 124 (01) :119-131
[9]   A CELLULAR ONCOGENE IS TRANSLOCATED TO THE PHILADELPHIA-CHROMOSOME IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
DEKLEIN, A ;
VANKESSEL, AG ;
GROSVELD, G ;
BARTRAM, CR ;
HAGEMEIJER, A ;
BOOTSMA, D ;
SPURR, NK ;
HEISTERKAMP, N ;
GROFFEN, J ;
STEPHENSON, JR .
NATURE, 1982, 300 (5894) :765-767
[10]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037